We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
RevBio, Inc., announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Aging, part of the National Institutes
Roche has secured the US Food and Drug Administration (FDA) 510(k) approval for cobas pure integrated solutions, its new-generation work area platform intended for low- to mid-volume labs.
AXIM Biotechnologies has signed an exclusive global commercial partnership agreement with Verséa Ophthalmics, a division of US-based healthcare company Verséa. Verséa specialises in the sale and distribution of
ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, and SANOFI announced the completion of the development of SoloSmart® today,
Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its PASCAL precision transcatheter valve repair system to treat patients with degenerative mitral regurgitation (DMR).
Konica Minolta Healthcare Americas, through its unit 20/20 Imaging, has received the US Food and Drug Administration (FDA) approval for its Chiropractic Straight Arm (CSA) system with Dynamic
Vesalio announces FDA HDE approval for commercialization of NeVa VS, indicated for the adjunct treatment of symptomatic cerebral vasospasm (CV) following aneurysmal subarachnoid hemorrhage (aSAH), the major cause of
Japanese biopharmaceutical company Takeda, in partnership with US-based diagnostics company Prometheus Laboratories, has rolled out the CDPATH programme in the US. CDPATH is a personalised prognostic test that
US-based percutaneous transcatheter devices maker Cardiac Implants has completed the first therapeutic adjustment procedure using its Tri-Ring percutaneous annuloplasty device. The procedure was conducted by a team of
Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Tasso+™ lancet as a